Current systemic therapies for psoriasis: Where are we now?

被引:41
|
作者
Yamauchi, PS
Rizk, D
Kormeili, T
Patnaik, R
Lowe, NJ
机构
[1] Clin Res Specialists, Santa Monica, CA 90404 USA
[2] Univ Calif Los Angeles, Sch Med, Div Dermatol, Los Angeles, CA 90024 USA
关键词
D O I
10.1016/mjd.2003.550
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Many systemic agents are used. in the treatment of psoriasis. They provide good control of psoriasis in the majority of patients and have improved their life quality indices. Frequently, combination therapy is utilized to synergize the efficacy of these medications. Many dermatologists are hesitant in prescribing systemic agents because of their adverse effects. However, such potential toxicities arising from these medications can largely be avoided if proper patient selection and close monitoring are performed.
引用
收藏
页码:S66 / S77
页数:12
相关论文
共 50 条
  • [11] Hydroxychloroquine in systemic and autoimmune diseases: Where are we now?
    Dima, Alina
    Jurcut, Ciprian
    Arnaud, Laurent
    JOINT BONE SPINE, 2021, 88 (03)
  • [12] Neuropsychiatric systemic lupus erythematosus: where are we now?
    Govoni, M.
    Rizzo, N.
    Castellino, G.
    Padovan, M.
    Trotta, F.
    REUMATISMO, 2005, 57 (04) : 215 - 225
  • [13] Molecular targeted therapies in breast cancer: Where are we now?
    Widakowich, Christian
    de Azambuja, Evandro
    Gil, Thierry
    Cardoso, Fatima
    Dinh, Phuong
    Awada, Ahmad
    Piccart-Gebhart, Martine
    INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2007, 39 (7-8): : 1375 - 1387
  • [14] An update on combination therapies for multiple sclerosis: where are we now?
    Sorensen, Per Soelberg
    Magyari, Melinda
    Sellebjerg, Finn
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2023, 23 (12) : 1173 - 1187
  • [15] Immune therapies in pancreatic ductal adenocarcinoma: Where are we now?
    Marc Hilmi
    Laurent Bartholin
    Cindy Neuzillet
    World Journal of Gastroenterology, 2018, (20) : 2137 - 2151
  • [16] Immune therapies in pancreatic ductal adenocarcinoma: Where are we now?
    Hilmi, Marc
    Bartholin, Laurent
    Neuzillet, Cindy
    WORLD JOURNAL OF GASTROENTEROLOGY, 2018, 24 (20) : 2137 - 2151
  • [17] Bench-to-bedside translation of stem cell therapies: where are we now and where are we going?
    Martino, Gianvito
    REGENERATIVE MEDICINE, 2016, 11 (04) : 347 - 349
  • [18] In defence of current treatment options:: where are we now?
    Völler, H
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2005, 7 (0E) : E4 - E9
  • [19] WHERE ARE WE NOW - SOME THOUGHTS ON CURRENT SCENE
    BERNARD, J
    PSYCHOLOGY OF WOMEN QUARTERLY, 1976, 1 (01) : 21 - 37
  • [20] Current Tools for Chemical Glycosylation: Where Are We Now?
    Karak, Milandip
    Haldar, Animeshchandra
    Torikai, Kohei
    TRENDS IN GLYCOSCIENCE AND GLYCOTECHNOLOGY, 2021, 33 (195) : E115 - E123